Published in Bull World Health Organ on January 01, 1987
Global eradication of poliomyelitis: benefit-cost analysis. Bull World Health Organ (1996) 1.99
Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog (2012) 1.50
A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas. Am J Public Health (1989) 1.44
Immunizing the children of the world: progress and prospects. Bull World Health Organ (1988) 1.17
Quest for life-long protection by vaccination. Proc Natl Acad Sci U S A (1994) 0.92
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am J Public Health (1989) 0.89
1889 to 1989: a century of health and disease. Public Health Rep (1990) 0.75
Outbreak of paralytic poliomyelitis, Taiwan. Lancet (1984) 1.68
Eradication of poliomyelitis in the United States. Rev Infect Dis (1983) 1.42
Serological comparisons of approaches to polio vaccination in the Gambia. Lancet (1987) 1.28
Actual causes of death in the United States. JAMA (1993) 28.34
Assessment of vaccination coverage, vaccination scar rates, and smallpox scarring in five areas of West Africa. Bull World Health Organ (1973) 12.31
Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. Am J Prev Med (2000) 6.43
Field evaluation of vaccine efficacy. Bull World Health Organ (1985) 4.95
Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA (1985) 3.85
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Morbidity and mortality associated with the July 1980 heat wave in St Louis and Kansas City, Mo. JAMA (1982) 3.69
Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med (2000) 3.65
Rational strategy for rubella vaccination. Lancet (1983) 3.61
Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev (1988) 3.51
Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann Intern Med (1988) 3.49
AIDS and absolutism--the demand for perfection in prevention. N Engl J Med (1992) 3.03
Measles vaccine efficacy in children previously vaccinated at 12 months of age. Pediatrics (1978) 2.98
The opportunity and obligation to eliminate measles from the United States. JAMA (1979) 2.93
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health (1985) 2.58
The immunization system in the United States - the role of school immunization laws. Vaccine (1999) 2.57
Tuberculosis symposium: emerging problems and promise. J Infect Dis (1993) 2.55
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med (1989) 2.41
Measles vaccination and Guillain-Barré syndrome. Lancet (1997) 2.36
The sample household health interview survey. Am J Public Health (1982) 2.35
Nutritional status of children in Nepal, 1975. Bull World Health Organ (1976) 2.34
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA (1987) 2.28
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet (1993) 2.24
Human monkeypox. Bull World Health Organ (1972) 2.18
A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol (1987) 2.13
Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol (1989) 2.12
Developing the Guide to Community Preventive Services--overview and rationale. The Task Force on Community Preventive Services. Am J Prev Med (2000) 2.10
Continuing measles transmission in students despite school-based outbreak control program. Am J Epidemiol (1985) 2.09
Improving immunization coverage rates: an evidence-based review of the literature. Epidemiol Rev (1999) 2.09
Use of health services. Am J Public Health (1982) 2.06
Highway violence and public policy. N Engl J Med (1987) 2.01
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA (1996) 1.93
Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol (1986) 1.93
Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med (1991) 1.92
From the Center for Disease control: current status of measles in the United States, 1973--1977. J Infect Dis (1978) 1.91
Progress in measles elimination. JAMA (1982) 1.87
Appropriate age for measles vaccination in the United States. Dev Biol Stand (1986) 1.80
Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med (1994) 1.79
Low measles incidence: association with enforcement of school immunization laws. Am J Public Health (1981) 1.79
Mortality and morbidity attributable to use of addictive substances in the United States. Proc Assoc Am Physicians (1999) 1.78
Current features of measles in the United States: feasibility of measles elimination. Epidemiol Rev (1980) 1.76
Costs of care. Am J Public Health (1982) 1.74
The resurgence of measles in the United States, 1989-1990. Annu Rev Med (1992) 1.72
Costs of immunization registries: experiences from the All Kids Count II Projects. Am J Prev Med (2000) 1.72
Health impact of measles vaccination in the United States. Pediatrics (1985) 1.71
Current status of mumps and mumps vaccine in the United States. Pediatrics (1978) 1.71
Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures. Am J Public Health (1987) 1.70
Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J (1990) 1.70
Outbreak of paralytic poliomyelitis, Taiwan. Lancet (1984) 1.68
Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet (1990) 1.67
Smallpox eradication in West and Central Africa. Bull World Health Organ (1975) 1.64
Health services in Shanghai County: introduction to Shanghai County. Am J Public Health (1982) 1.63
Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs. JAMA (1984) 1.59
Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine. Pediatrics (1989) 1.57
Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis (1992) 1.55
Rubella vaccination in the United States: a ten-year review. Epidemiol Rev (1980) 1.53
Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol (2001) 1.53
An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease. Am J Epidemiol (1989) 1.53
Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med (1981) 1.52
Elimination of indigenous measles from the United States. Rev Infect Dis (1983) 1.50
Fetal risk associated with rubella vaccine: an update. Rev Infect Dis (1985) 1.50
Public health: moving from debt to legacy. Am J Public Health (1987) 1.47
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol (1984) 1.47
Selective epidemiologic control in smallpox eradication. Am J Epidemiol (1971) 1.46
Causes of low preschool immunization coverage in the United States. Annu Rev Public Health (1992) 1.45
Closing the gap. Report of the Carter Center Health Policy Consultation. JAMA (1985) 1.44
Resurgence of measles in New York. Am J Public Health (1972) 1.43
1918 influenza, encephalitis lethargica, parkinsonism. Lancet (1982) 1.43
The effect of disease prior to an outbreak on estimates of vaccine efficacy following the outbreak. Am J Epidemiol (1995) 1.43
Global progress in infectious disease control. Vaccine (1998) 1.42
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob Agents Chemother (1984) 1.42
The Russian flu. Its history and implications for this year's influenza season. JAMA (1978) 1.41
A million dollar measles outbreak: epidemiology, risk factors, and a selective revaccination strategy. Public Health Rep (1992) 1.41
An appeal for nuclear sanity: an open letter to: Prime Minister Atal Behari Vajpayee of India: Prime Minister Nawaz Sharif of Pakistan. JAMA (1998) 1.40
Evaluation of telephoned computer-generated reminders to improve immunization coverage at inner-city clinics. Public Health Rep (1993) 1.40
Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis (1985) 1.39
DTP vaccine litigation, 1988. Am J Dis Child (1990) 1.39
Measles surveillance--United States, 1991. MMWR CDC Surveill Summ (1992) 1.38
Pneumonic tularemia on Martha's Vineyard. N Engl J Med (1979) 1.36
Centers for Disease Control. J Public Health Policy (1981) 1.36
Pertussis--a disease and a vaccine that are not going away. West J Med (1989) 1.35
Epidemiologic study of Guillain-Barré syndrome in children <15 years of age in Latin America. J Infect Dis (1997) 1.33